β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.
about
β-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1/2 and Akt.Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.Pressure overload induces IL-18 and IL-18R expression, but markedly suppresses IL-18BP expression in a rabbit model. IL-18 potentiates TNF-α-induced cardiomyocyte deathInduction of M2 regulatory macrophages through the β2-adrenergic receptor with protection during endotoxemia and acute lung injury.IL-27 Regulates IL-18 binding protein in skin resident cellsIsoproterenol induces vascular oxidative stress and endothelial dysfunction via a Giα-coupled β2-adrenoceptor signaling pathwayCIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.Bidirectional cross-regulation between ErbB2 and β-adrenergic signalling pathways.PDE1C deficiency antagonizes pathological cardiac remodeling and dysfunction.Specific α7 nicotinic acetylcholine receptor agonist ameliorates isoproterenol-induced cardiac remodeling in mice through TGF-β1/Smad3 pathway.Insulin and β Adrenergic Receptor Signaling: Crosstalk in Heart.Overview of the IL-1 family in innate inflammation and acquired immunity.Echocardiographic assessment of β-adrenoceptor stimulation-induced heart failure with reduced heart rate in mice.
P2860
Q33680497-18D1DCB2-FE34-4C0A-A7FB-3A8422F136ADQ33801215-8736892C-E502-46A8-AA71-B833E00EB1CAQ34150569-18DF924B-E03B-4F9F-9CBA-E9020FFB570AQ34157473-8304DBBB-8113-4493-9770-C51039975603Q34325776-BB8EC4E8-BAC4-431E-817C-748A0260B85FQ35119132-40772A7B-47F5-4B70-8579-9E5867F75869Q36337179-331AD16A-B141-48B0-8714-22CB7C8A7831Q36575695-927AF739-B25A-4674-8E49-6B67200D3DE9Q37417757-264976AA-54F0-4D8B-9F88-BA9DCA66F6B1Q38667881-62649C22-92D1-45F5-A17E-7E52BD0DB1AFQ39159635-3A77F826-FBDB-4D78-B6EE-CBBDDF05710EQ47285878-5871AAE3-4168-4006-9C5D-798F04E5E30EQ47963339-DCC073A2-5704-4ACE-B7EF-22C8618DADF1
P2860
β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
β2 adrenergic activation induc ...... yocardial hypertrophy in vivo.
@en
β2 adrenergic activation induc ...... yocardial hypertrophy in vivo.
@nl
type
label
β2 adrenergic activation induc ...... yocardial hypertrophy in vivo.
@en
β2 adrenergic activation induc ...... yocardial hypertrophy in vivo.
@nl
prefLabel
β2 adrenergic activation induc ...... yocardial hypertrophy in vivo.
@en
β2 adrenergic activation induc ...... yocardial hypertrophy in vivo.
@nl
P2093
P2860
P50
P1476
β2 adrenergic activation induc ...... yocardial hypertrophy in vivo.
@en
P2093
Anthony J Valente
Bysani Chandrasekar
David R Murray
Naveen K Somanna
Srinivas Mummidi
P2860
P304
P356
10.1016/J.YJMCC.2011.09.022
P577
2011-10-08T00:00:00Z